Epidemiology

Kerr, S, Robertson, C, Hillman, S, Grange, Z et al.
Letter: Severity of Omicron BA.2 variant and vaccine effectiveness against symptomatic disease in Scotland.
International Journal of Epidemiology.

Kerr S, Bedston S, Bradley DT, Joy M, Lowthian E, Mulholland RM et al.
Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales.
International Journal of Epidemiology.

Agrawal A, Bedston S, McCowan C, Oke J, Patterson L, Robertson C et al.
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
The Lancet.

Simpson CR, Kerr S, Katikireddi S.V, McGowan C, et.al,
Second-dose Oxford-AstraZeneca and Pfizer-BioNTech vaccines and blood clotting and bleeding events in Scotland.
Nature Communications.

PHOSP-COVID Collaborative Group,
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
The Lancet Respiratory Medicine.

Kerr S, Joy M, Torabi F, Bedston S, Akbari A, Agrawal U et al,
First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 12 million individuals in England, Scotland and Wales.
PLOS medicine.

Agrawal U, Katikireddi SV, McCowan C, Mulholland RH, Azcoaga-Lorenzo A, Amele S, Fagbamigbe et al
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study .
The Lancet Respiratory Medicine.

Sheikh A, Kerr S, Woolhouse M, McMenamin J, Robertson C,
Severity of Omicron variant of concern and vaccine effectiveness against symptomatic disease: national cohort with nested test negative design study in Scotland - preprint , publication - Lancet Infectious Diseases.

Ting S, P Jiafeng, Katikireddi V, McCowan C, Kerr S, Agrawal U et al,
Risk of COVID-19 hospital admission among children aged 5–17 years with asthma in Scotland: a national incident cohort study.
The Lancet Respiratory Medicine.

Simpson CR, Kerr S, Shi T, Vasileiou E, Moore E, McCowan C et al,
External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland.
Thorax.

Simpson CR, Shi T, Vasileiou E, Katikireddi SV, Kerr S, Moore E et al,
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
Nature Medicine.

PHOSP-COVID Collaborative Group,
Physical, cognitive and mental health impacts of COVID-19 following hospitalisation -- a multi-centre prospective cohort study.
The Lancet Respiratory Medicine.

Vasileiou E, Simpson CR, Robertson C, Shi T, Kerr S, et al,
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.
The Lancet.